1887

Abstract

The penicillin-binding protein 2a (PBP2a) assay is a quick, accurate and inexpensive test for determining methicillin susceptibility in . A pre–post-study design was conducted using a PBP2a assay with and without the impact of an antimicrobial stewardship intervention to improve time to optimal therapy for methicillin-susceptible and methicillin-resistant isolates. Our results demonstrate significantly improved time to optimal therapy and support the use of a PBP2a assay as part of an programme for all healthcare facilities, especially those with limited resources.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.000365
2016-12-16
2020-03-28
Loading full text...

Full text loading...

/deliver/fulltext/jmm/65/12/1452.html?itemId=/content/journal/jmm/10.1099/jmm.0.000365&mimeType=html&fmt=ahah

References

  1. Alere 2016; PBP2a culture colony test. http://www.alere.com/en/home/product-details/pbp2a.html Accessed 7.31.2016
  2. Bauer K. A., West J. E., Balada-Llasat J. M., Pancholi P., Stevenson K. B., Goff D. A.. 2010; An antimicrobial stewardship program's impact with rapid polymerase chain reaction methicillin-resistant Staphylococcus aureus/S. aureus blood culture test in patients with S. aureus bacteremia. Clin Infect Dis51:1074–1080 [CrossRef][PubMed]
    [Google Scholar]
  3. Bauer K. A., Perez K. K., Forrest G. N., Goff D. A.. 2014; Review of rapid diagnostic tests used by antimicrobial stewardship programs. Clin Infect Dis59:S134–S145 [CrossRef][PubMed]
    [Google Scholar]
  4. Brown J., Paladino J. A.. 2010; Impact of rapid methicillin-resistant Staphylococcus aureus polymerase chain reaction testing on mortality and cost effectiveness in hospitalized patients with bacteraemia: a decision model. Pharmacoeconomics28:567–575 [CrossRef][PubMed]
    [Google Scholar]
  5. CDC 2014; The Center for Disease Control and Prevention: Core Elements of Hospital Antibiotic Stewardship Programs. http://www.cdc.gov/getsmart/healthcare/implementation/core-elements.html Accessed 7.31.2016
  6. CLSI 2016; Performance Standards for Antimicrobial Susceptibility Testing, twenty-sixth informational supplement. CLSI document M100-S26. Wayne, PA: Clinical and Laboratory Standards Institute;
    [Google Scholar]
  7. Cosgrove S. E., Sakoulas G., Perencevich E. N., Schwaber M. J., Karchmer A. W., Carmeli Y.. 2003; Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis. Clin Infect Dis36:53–59 [CrossRef][PubMed]
    [Google Scholar]
  8. Forrest G. N., Mehta S., Weekes E., Lincalis D. P., Johnson J. K., Venezia R. A.. 2006; Impact of rapid in situ hybridization testing on coagulase-negative staphylococci positive blood cultures. J Antimicrob Chemother58:154–158 [CrossRef][PubMed]
    [Google Scholar]
  9. Mosammaparast N., McAdam A. J., Nolte F. S.. 2012; Molecular testing for infectious diseases should be done in the clinical microbiology laboratory. J Clin Microbiol50:1836–1840 [CrossRef][PubMed]
    [Google Scholar]
  10. Newcombe R. G.. 1998; Two-sided confidence intervals for the single proportion: comparison of seven methods. Stat Med17:857–872 [CrossRef][PubMed]
    [Google Scholar]
  11. Nicolsen N. C., LeCroy N., Lecroy N., Alby K., Martin K. E., Laux J., Lin F. C., Daniels L., Weber D. J., Miller M. B.. 2013; Clinical outcomes with rapid detection of methicillin-resistant and methicillin-susceptible Staphylococcus aureus isolates from routine blood cultures. J Clin Microbiol51:4126–4129 [CrossRef][PubMed]
    [Google Scholar]
  12. Schweizer M. L., Furuno J. P., Harris A. D., Johnson J. K., Shardell M. D., McGregor J. C., Thom K. A., Cosgrove S. E., Sakoulas G., Perencevich E. N.. 2011; Comparative effectiveness of nafcillin or cefazolin versus vancomycin in methicillin-susceptible Staphylococcus aureus bacteremia. BMC Infect Dis11:279–285 [CrossRef][PubMed]
    [Google Scholar]
  13. TJC 2013; The Joint Commission: Antimicrobial Stewardship Toolkit SKU# FR1007. http://www.jcrinc.com/antimicrobial-stewardship-toolkit/ Accessed on 31 July 2016
  14. TJC 2016; The Joint Commission: Joint Commission unveils new antimicrobial stewardship standard. https://www.jointcommission.org/issues/article.aspx?Article=8/edJxSI/ROgKZhv46xb1vQ5282rP1aYDfaGA3GiMJM%3D Accessed on 31 July 2016
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.000365
Loading
/content/journal/jmm/10.1099/jmm.0.000365
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error